Antipruritic vs. Antitumour Action of Aprepitant: A Question of Dose. [electronic resource]
Producer: 20191212Description: 620-621 p. digitalISSN:- 1651-2057
- Antineoplastic Agents -- administration & dosage
- Antipruritics -- administration & dosage
- Aprepitant -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Humans
- Lymphoma, T-Cell, Cutaneous -- complications
- Neurokinin-1 Receptor Antagonists -- administration & dosage
- Pruritus -- drug therapy
- Skin Neoplasms -- complications
- Treatment Outcome
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.